Screener
Kestra Medical Technologies KMTS Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Kestra Medical Technologies in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Kestra Medical Technologies’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 5:16 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001193125-26-303397
| Line item | Year Ended April 30, 2026 | Year Ended April 30, 2025 |
|---|---|---|
| Accrued liabilities | 8,197 | 4,617 |
| Operating lease liabilities | (685) | 370 |
| Other long-term assets | 40 | 40 |
| Net cash used in operating activities | (81,703) | (77,608) |
| Cash flows from investing activities | ||
| Purchases of property and equipment | (34,892) | (22,936) |
| Deposits for medical rental equipment | (528) | (655) |
| Refund of deposits for medical rental equipment | 184 | 283 |
Item 16. Form 10-K Summary.
FAQ
- What is Kestra Medical Technologies's operating cash flow?
- Kestra Medical Technologies (KMTS) reported operating cash flow of -$18.72M in Q1 2026.
- How has Kestra Medical Technologies's operating cash flow changed year-over-year?
- Kestra Medical Technologies's operating cash flow increased by 22.2% year-over-year, from -$24.06M to -$18.72M.
- What is the long-term trend for Kestra Medical Technologies's operating cash flow?
- Over 2 years (2024 to 2026), Kestra Medical Technologies's operating cash flow has grown at a 6.4% compound annual growth rate (CAGR), from -$72.24M to -$81.7M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Kestra Medical Technologies's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude